Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Frequency and Clinical Significance of Epstein-Barr Virus Antibody Titers in Egyptian Patients With Multiple Sclerosis

NCT07846943 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07846943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07846943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Frequency and Clinical Significance of Epstein-Barr Virus Antibody Titers in Egyptian Patients With Multiple Sclerosis
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
November 30, 2027
Enrollment
140 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epstein-barr virus (ebv) infection, epstein-barr virus infections, multiple sclerosis